It looks like PTC Therapeutics will have to carry out another clinical trial of its drug candidate for inherited neuromuscular disorder Friedreich's ataxia (FA) before the FDA will consider approval.
In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...
Raymond's aerospace opportunity has been strengthened through its integration of Maini Precision Products (MPPL), completed in 2024-25. (Image: AI generated.) Follow Us India is emerging as a key ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
PTC Industries shares rose as much as 18 percent on Monday after global brokerage Goldman Sachs reiterated its "buy" rating on the stock following the company's March quarter earnings and projected an ...
Mukul Agrawal-owned PTC Industries surges 19.5% after Q4 results. Do you own this multibagger stock?
Multibagger stock PTC Industries kickstarted the new month on a bullish note, rallying a whopping 19.5% in intraday deals today, 1 June, following the announcement of its March quarter results for the ...
With the writing apparently on the wall, PTC Therapeutics has called off its latest bid for FDA approval of its Duchenne muscular dystrophy (DMD) drug Translarna. Late Thursday, PTC revealed that it ...
PTC Inc. (PTC) recently reported its FQ4 2025 financial results, beating both revenue and earnings estimates. I previously analyzed PTC in June with a Hold outlook due to cautious client ...
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to PTC's 2025 Fourth Quarter Conference Call. [Operator Instructions] I would now like to turn the call over to Matt Shimao ...
Seth MacFarlane once famously called the PTC "like getting hate mail from Hitler." Now they've filed for Chapter 11. By James Hibberd Writer-at-Large The organization’s tagline was “Because Our ...
NHPC is unwilling to sell its stake in the power trading joint venture although it had, while shelving its buyout plan, said power trading was not its core business. New Delhi: After NHPC Ltd dropped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results